EUVIMEDEUVIMED entdecken
Open Access

Dose-fractionation studies of a Plasmodium phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria

Liezl Gibhard iD, Mathew Njoroge, Mwila Mulubwa, Nina Lawrence, Dennis Smith, James Duffy, Claire Le Manach, Christel Brunschwig, Dale Taylor, Renier van der Westhuyzen, Leslie J Street, Gregory S Basarab iD und 1 weitere

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00842-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Liezl Gibhard und 12 weiteren Autor:innen. Beteiligte Einrichtung: Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Rondebosch, South Africa. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, 1-Phosphatidylinositol 4-Kinase, Disease Models, Animal. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Technology Innovation Agency (TIA), Strategic Health Innovation Partnerships (SHIP) unit of the South African Medical Research Council (SAMRC), Medicines for Malaria Venture (MMV).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

UCT594 is a 2-aminopyrazine carboxylic acid Plasmodium phosphatidylinositol 4-kinase inhibitor with potent asexual blood-stage activity, the potential for interrupting transmission, as well as liver-stage activities. Herein, we investigated pharmacokinetic/pharmacodynamic (PK/PD) relationships relative to blood-stage activity toward predicting the human dose. Dose-fractionation studies were conducted in the Plasmodium falciparum NSG mouse model to determine the PK/PD indices of UCT594, using the in vivo minimum parasiticidal concentration as a threshold. UCT594 demonstrated concentration-dependent killing in the P. falciparum -infected NSG mouse model. Using this data and the preclinical pharmacokinetic data led to a low predicted human dose of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsPlasmodium falciparum1-Phosphatidylinositol 4-KinaseDisease Models, AnimalMalaria, FalciparumAnimalsMiceHumansDose-Response Relationship, DrugFemaleParasitic Sensitivity Tests

Stichwörter der Autor:innen

1-phosphatidylinositol 4-kinase inhibitordose-fractionation studiesdrug discoverydrug metabolism and pharmacokineticshuman dose predictionin vivo efficacymalariapharmacokinetic/pharmacodynamic modelling

Substanzen

Antimalarials1-Phosphatidylinositol 4-Kinase

Autor:innen und Institutionen

  • Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Rondebosch, South Africa.
  • Independent Researcher, Kent, United Kingdom.
  • Medicines for Malaria Venture, ICC, Geneva, Switzerland.
  • South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa.

ORCID-Profile: Liezl Gibhard, Gregory S Basarab

Förderung

  • Technology Innovation Agency (TIA)
  • Strategic Health Innovation Partnerships (SHIP) unit of the South African Medical Research Council (SAMRC)
  • Medicines for Malaria Venture (MMV)
  • Neville Isdell
  • South African National Research Foundation

Zitieren

APA

Gibhard, L., Njoroge, M., Mulubwa, M., Lawrence, N., Smith, D., Duffy, J., Le Manach, C., Brunschwig, C., Taylor, D., van der Westhuyzen, R., Street, L. J., Basarab, G. S., & Chibale, K. (2024). Dose-fractionation studies of a Plasmodium phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00842-24

Vancouver

Gibhard L, Njoroge M, Mulubwa M, Lawrence N, Smith D, Duffy J, et al. Dose-fractionation studies of a Plasmodium phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00842-24

BibTeX
@article{Gibhard2024,
  author = {Gibhard, Liezl and Njoroge, Mathew and Mulubwa, Mwila and Lawrence, Nina and Smith, Dennis and Duffy, James and Le Manach, Claire and Brunschwig, Christel and Taylor, Dale and van der Westhuyzen, Renier and Street, Leslie J and Basarab, Gregory S and Chibale, Kelly},
  title = {Dose-fractionation studies of a Plasmodium phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00842-24}
}
Kostenlos starten →